Biocatalyst Foundation’s Post

At Gate2Brain, we are thrilled 🎉to announce that we have been granted the Innovator's Pitch Challenge Award at RESI Europe 2024, which made its debut in Barcelona. 🏆 We want to extend our heartfelt congratulations to YSOTOPE THERANOSTICS and DyCare, as well as all the participants who made the competition so inspiring. The event featured engaging pitch sessions and insightful debates, providing a valuable platform for innovation and collaboration. We would like to thank the organizers and institutions that made this significant event possible in Barcelona: #RESIEurope was held in Barcelona thanks to the collaboration of the event's organizer, Life Science Nation, with Biocat, BioRegion of Catalonia as the local co-organizer, the Barcelona City Council (Ajuntament de Barcelona) and the Government of Catalonia (Generalitat de Catalunya), and support from Biotechgate It was a fantastic day to share our project, mission, and investment opportunities, while also building bridges and welcoming RESI to Europe!! Together, we can empower tomorrow’s solutions today. Gate2Brain, bringing medicines beyond barriers. #RESIEUROPE #RESIBARCELONA #biotech #startup #medicinesbeyondbarriers #funding #investment

🌟 Inspiring insights from #EICAccelerator Startups 🌟 🔬 Innovation in #MicrobiomeResearch. We had the honor of hosting Sebastião van Uden, CEO and Co-Founder of Bac3Gel® Lda, a Portuguese startup which has developed a technology to produce artificial #mucus that mimics the characteristics of different body environments - such as the gut, lungs, stomach, and vagina -in both healthy and pathological conditions. 🦠 This technology enables precise #modeling of #microbial ecosystems and allows researchers to study the impact of therapeutic molecules on complex bacteria communities. What sets Bac3Gel® Lda apart is its ability to combine scientific accuracy with practical application, offering compatibility with high-throughput systems and advanced testing methods. This opens exciting possibilities for breakthroughs in #antibiotic research, #probiotics development, and more. 🧪 We were inspired by the potential Bac3Gel® Lda holds to advance microbial and therapeutic research, paving the way for new health solutions. Spherik Accelerator | FastTrack Ventures | G-Force | F6S Innovation European Innovation Council and SMEs Executive Agency (EISMEA) #Innovation #Microbiome #Biotechnology #StartupJourney #AccelerationProgram

Roundtable Recap: #BioTech, #MedTech, #EnergyAndDecarbonization The Horizon Deep Tech Summit is just around the corner! Don’t miss out on insightful roundtables featuring industry leaders, innovators and investors. 🌍💡 Here's a reminder of what’s in store: 🧪 BioTech: Financing and Scaling Biotech Ventures from Lab to Launch Myriam Rouis, CFA (European Investment Bank (EIB)), Beatrice Jobst (Kriba), Guido Kurz (Oncostellae), Santi Dominguez (Noso Capital), Marisa Tejedor Botello (Fundación Botín) 🩺 MedTech: Transforming Healthcare with AI and Innovation in MedTech Antonio Rodríguez Hita (EIT Health), Alberto Aguilar Montoro (DIGITAL ANATOMICS), Jorge Tello Guijarro (Savana), Laura Soto Polo (Plug and Play Tech Center), Lola Franco Valero (Scale Up Partner) ⚡ Energy & Decarbonization: Driving Innovation and Investment for Decarbonization and Energy Transition Fernando Lelo de Larrea H. (Rumbo Ventures), Joaquin Chacon (Zelestium Technologies), Michiel Poppink (KapiteinLabs), Juan Antonio Añel Cabanelas (Universidade de Vigo), Diego Mendez ( Plug and Play Tech Center) Haven’t purchased tickets yet? It’s not too late! Visit https://lnkd.in/dA3ktzkY.

Loft Science coaches shared their insights at the K-BioX Global AI Bio Summit! Our expert panelists, including Margarette Ell-Kesselman (Stanford LEAD CF), Scully Wang (Sylcon Marketing), Vinita Soin (KNAV),Tanya O. (JHTC), and Wojciech (Voytek) Majewski (Sojo Consulting), shared invaluable insights on turning research into business success in the biotech industry. Key takeaways: - Critical factors for starting a biotech company - Fundamental marketing aspects for launching a biotech business in the US - Financial considerations for early-stage biotech companies - Strategies for foreign startups to establish a network in Silicon Valley - Facilitating global growth for biotech companies A huge thank you to our panelists and attendees! #KBioX #SiliconValley #Biotech #Startup #Innovation #LoftScience

👀 A look back at the Start-up Meet'in 2024 👀 The event for #MedTech, #BioTech, and #GreenTech start-ups to connect with industry experts. With more than 160 participants bringing together 12 speakers, 107 experts, and 40 start-ups, the 2024 edition of Start-up Meet'in, keep its status as a must-attend event for the Start-up, Spin-off, and Scale-up ecosystem! 👏👏 Before the event itself, there were 3 pitch sessions (Biotech, Medtech & Greentech) organized by Mind and Market where 15 start-ups were able to present and defend their projects in front of a jury of experts. A good start to the day.💪 The day kicked off with the "Start-up Experience Panel," where experts shared their journeys, highlighting both triumphs and challenges. - Grégoire Talbot - D-Carbonize - Pierre de Schaetzen - Billy Bike - Anne Wautier - BNP Paribas Fortis - Bertrand Loriers - Secoya Technologies - Philippe Durieux - VIVES Partners Following this, we had 2 hours of speed dating sessions, allowing start-ups and experts to engage in meaningful, short discussions on a variety of crucial topics. 🗨️👨👩💬 The afternoon featured a second expert panel on "How Big Pharma, Financing, Digitalization, and Sustainability Drive Innovation and Growth of Start-ups." Our gratitude goes to these insightful panelists: - Emmanuel Amory - GSK - Philippe Chevalier - N-SIDE - Claire Munck - BeAngels - Xavier Hormaechea - UCB - Fanny Deliège - Agence du Numérique (AdN) The event concluded with a networking dinner to go deeper in the previous discussions or to begin new ones. 🍻🍽️ A big thank you to our inspiring speakers who participate to the success of this event. 🎤 Also a big thanks to the other partners of this event: BNP Paribas Fortis, GSK & Agence du Numérique (AdN) and of course to the organizer: Cercle du Lac 😉 After creating this event 3 years ago, #Analis is proud to always be a partner and to support events like these that foster growth and innovation in the start-up's sector.🔝 Need more information or want to connect with our experts? 👉https://lnkd.in/eyJVqv8z

⚙️ 💥 WE Life Sciences, how does it work and how do we operate?   📈 WE Life Sciences plays a key role in the financial support of the life sciences sector in Wallonia, accompanying biotech or medtech companies throughout their life cycle, from the start-up phase to maturity.   🧪 Thanks to a network of experts and international investors, we are involved at every stage of innovation: from preclinical research to the marketing of products or molecules. Our support enables companies to overcome critical obstacles and increase their attractiveness to private investors. This approach strengthens innovative ecosystems and maximises the chances of success on a global scale.   🚀 A new or ongoing Life Sciences project? Get in touch with our team of investors! (link in comment of this post) 👇   #lifesciences #biotech #medtech #innovation #startup Gery Lefebvre Wallonie Entreprendre

𝗦𝘆𝗻𝗕𝗶𝗼 𝗳𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗩𝗖 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗼𝗿 𝗗𝗲𝗲𝗽 𝗧𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 Synthetic biology (#SynBio) isn't just about science; it's also about how these scientific innovations are turned into products and solutions that meet market needs. Its applications are extensive, ranging from enhancing food flavors to revolutionizing carbon sequestration practices through innovative uses of natural systems and genetic engineering. However, the path from #lab to #market can be challenging for #founders, from building a scalable plan to navigating regulatory matters. We had the pleasure of hosting Chloë Payne, Principal at Ponderosa Ventures, to cover the basics of the SynBio industry and help aspiring #STEM founders take their first steps into #entrepreneurship. Key themes covered: 🧬 Understanding Synthetic Biology (SynBio) and Its Applications 🗺️ Navigating Regulatory Scenarios in the Food Industry 🎯 Pricing Strategy Basics for SynBio Innovations 📈 Capital Efficiency and Scalability in Synthetic Biology Innovation 🎯 Green Lights and Red Flags for VCs in Early-Stage SynBio > Catch the full conversation here: https://lnkd.in/dBQqxwMz #startup #startups #innovation #technology #manufacturing #industry #vcs #venturecapital #techtransfer #deeptech #hardtech #industry #tech #strategy #founders #technology #phd #science #foodtech #biotech #DeepTechCatalyst ----- 📣 Follow The Scenarionist to get exclusive insights at the intersection of Deep Tech and Venture Capital, every week!

We are celebrating! biosimulytics has successfully completed our 1-year review for the prestigious #EICAccelerator Programme! For those who may not be familiar, the European Innovation Council (EIC) is an initiative by the European Commission aimed at supporting high-risk, high-impact innovations. The EIC Accelerator Programme is one of the most selective and competitive funding programmes under Horizon Europe and is designed to support the most innovative start-ups and SMEs with breakthrough products, services, and business models that have the potential to create new markets or disrupt existing ones. The 1-year review is an in-depth evaluation that includes: 🔹 Progress Assessment: Evaluating the milestones achieved against our initial project plan and assessing our technical and commercial progress. 🔹 Financial Review: Examining our financial management and expenditure of the grant funds to ensure they have been used appropriately and effectively. 🔹 Impact Evaluation: Analyzing our project’s impact on the market and its potential to create new markets or disrupt existing ones, as well as its societal and economic benefits. 🔹 Future Plans: Assessing our plans for the next phases of development and commercialization and evaluating our strategies for scaling up and achieving long-term sustainability. This milestone is a testament to the impact of our platform thanks to the hard work and dedication of our team. We are beyond excited about the future and immensely grateful for the support from the EIC Accelerator. A huge thank you to our dedicated team, partners, and supporters who have been with us on this incredible journey! #Innovation #Milestone #Growth #InvestInInnovation #Biotech #HealthTech #DeepTech #StartUp European Innovation Council and SMEs Executive Agency (EISMEA) NovaUCD Viridien

We are thrilled to announce that the second edition of the HealthTech Investor Summit, a premier international event in the #healthtech sector, taking place in #Bruges is starting #today, December 9th, and will last till December 11th. Following the success of the first edition in 2023, this summit offers great opportunities for networking, innovation, and growth for the different actors in the health ecosystem.🧬   Organized by MEDVIA, the #Flemish innovation cluster for #medtech and #biotechnology, this summit is the perfect place for companies, startups, investors, research institutes, universities, hospitals, and patient advocacy groups to connect and collaborate.   Highlights from the first edition:   👥 400+ participants over 3 days 💼 60+ investors 🎤 75 pitches from companies and startups 📚 25 knowledge partners 🤝 32 sponsors 🌍 18 nationalities   What the Healthtech Investor Summit 2024 offers:   #Pitching: Pre-seed, startup, and scale-up pitches from across Europe #Panels: High-level discussions on current topics #Partnering: Top-quality partnering sessions #VIPActivities: Customized side-events, including an investor-only dinner   Learn more and follow the latest updates here: https://lnkd.in/esusfD8p   Marleen Verstreken | Flanders Investment & Trade (FIT) MEDVIA | HealthTech Investor Summit

As MassBio releases its 5-year strategic plan today, I'm thrilled to share key insights from my recent podcast conversation with Jason Cordeiro, Chief Operating and Innovation Officer. I had no idea about some of these programs, so I bet you'll learn something new even if you think you know all about MassBio! Here are some key takeaways from our conversation: 🌱 Nurturing Early-Stage Companies: MassBio is launching a Launchpad program to provide roadmaps and potential partners for startups, along with plans for a seed fund linked to their MassBio Drive accelerator. 🤖 Embracing AI and Tech: There's a strong focus on supporting AI-driven drug development and "tech for biotech" companies, recognizing the importance of digital innovation in the industry's future. 💰 Expanding Investor Base: MassBio is developing a program to demystify life sciences investing and attract new funders to the sector. 🧬 Fostering Diverse Talent: The successful Biodiversity initiative is expanding, with plans to develop targeted programs in different communities plus a new focus on executive-level talent development in partnership with The Termeer Foundation. 📣 Amplifying Industry Impact: MassBio aims to better communicate the biotech industry's story to lawmakers and the public, emphasizing its broader impact beyond financial metrics. These initiatives are part of MassBio's comprehensive strategy to maintain Massachusetts' leadership in the biotech sector. I'm excited to see how these plans unfold over the next five years! #Biotech #MassBio #Innovation #LifeSciences #AIinHealthcare Don't miss the full conversation! Link to podcast in comments.